NCT03391362View on ClinicalTrials.gov

Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2026

Conditions
Brain MetastasesSmall Cell Lung Cancer
Interventions
RADIATION

Stereotactic Radiation

Stereotactic radiation involves using a high dose of radiation that only targets the specific metastases

Trial Locations (1)

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT03391362 - Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases | Biotech Hunter | Biotech Hunter